SMAD2 mRNA expression was unaltered in aortas of T2D patients when compared to control subjects whereas ZEB2 was significantly downregulated (SMAD2 not significant; ZEB2, 4.1-fold, p < 0.05, Fig. 2D). The gene discussed is SMAD2; the disease is type 2 diabetes mellitus.